Medications for Disseminated Neuroblastoma

5 results

  • cyclophosphamide

    (Cyclophosphamide)
    NorthStar RxLLC
    Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to corticosteroids.

  • cyclophosphamide

    (cyclophosphamide)
    Baxter Healthcare Corporation
    Cyclophosphamide for Injection is indicated for treating various malignancies in adults and pediatric patients, including malignant lymphomas, multiple myeloma, leukemias, and specific cancers like breast and ovarian carcinoma. It's also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy fails.

  • cyclophosphamide

    (cyclophosphamide)
    Civica, Inc.
    Cyclophosphamide for Injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome unresponsive to corticosteroids.

  • cyclophosphamide

    (Cyclophosphamide)
    Amneal Pharmaceuticals LLC
    Cyclophosphamide for injection is indicated for treating various malignant diseases, including specific types of lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, and certain carcinomas. It is also used in pediatric patients with biopsy-proven minimal change nephrotic syndrome who do not respond to steroid therapy.

  • cyclophosphamide

    (cyclophosphamide)
    Bamboo US Bidco LCC
    Cyclophosphamide is indicated for treating various malignant diseases, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids. Safety in adults for this condition is not established.